Shenzhen Edge Medical Executes HKD 12.08 Million Share Buyback, Boosts Treasury Stock to 663,800 Shares

Bulletin Express06-18

Shenzhen Edge Medical Co., Ltd. disclosed that it repurchased 310,600 H shares on 18 June 2026 via on-market transactions. The shares were bought at prices ranging between HKD 38.30 and HKD 39.00, translating into a volume-weighted average cost of HKD 38.88 per share and a total consideration of HKD 12.08 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.09% to 327.10 million shares, while total issued shares remained unchanged at 327.76 million. The repurchased stock has been retained as treasury shares, lifting the treasury balance from 353,200 to 663,800 shares.

The buyback was executed under the mandate approved on 18 June 2025, which authorises repurchases of up to 32.36 million shares. Cumulative repurchases under this authority now stand at 663,800 shares, equivalent to 0.21% of the share base on the mandate date.

In line with Hong Kong listing regulations, the company confirmed full compliance with all applicable rules and statutory requirements. A 30-day moratorium on new share issues or sales of treasury shares is in place until 18 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150762872?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150762872","market":"hk","top_or_hot":-1,"title":"Shenzhen Edge Medical Executes HKD 12.08 Million Share Buyback, Boosts Treasury Stock to 663,800 Shares","media":"Bulletin Express","content":"<p>Shenzhen Edge Medical Co., Ltd. disclosed that it repurchased 310,600 H shares on 18 June 2026 via on-market transactions. The shares were bought at prices ranging between HKD 38.30 and HKD 39.00, translating into a volume-weighted average cost of HKD 38.88 per share and a total consideration of HKD 12.08 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.09% to 327.10 million shares, while total issued shares remained unchanged at 327.76 million. The repurchased stock has been retained as treasury shares, lifting the treasury balance from 353,200 to 663,800 shares.</p>\n<p>The buyback was executed under the mandate approved on 18 June 2025, which authorises repurchases of up to 32.36 million shares. Cumulative repurchases under this authority now stand at 663,800 shares, equivalent to 0.21% of the share base on the mandate date.</p>\n<p>In line with Hong Kong listing regulations, the company confirmed full compliance with all applicable rules and statutory requirements. A 30-day moratorium on new share issues or sales of treasury shares is in place until 18 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen Edge Medical Executes HKD 12.08 Million Share Buyback, Boosts Treasury Stock to 663,800 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen Edge Medical Executes HKD 12.08 Million Share Buyback, Boosts Treasury Stock to 663,800 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-18 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shenzhen Edge Medical Co., Ltd. disclosed that it repurchased 310,600 H shares on 18 June 2026 via on-market transactions. The shares were bought at prices ranging between HKD 38.30 and HKD 39.00, translating into a volume-weighted average cost of HKD 38.88 per share and a total consideration of HKD 12.08 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.09% to 327.10 million shares, while total issued shares remained unchanged at 327.76 million. The repurchased stock has been retained as treasury shares, lifting the treasury balance from 353,200 to 663,800 shares.</p>\n<p>The buyback was executed under the mandate approved on 18 June 2025, which authorises repurchases of up to 32.36 million shares. Cumulative repurchases under this authority now stand at 663,800 shares, equivalent to 0.21% of the share base on the mandate date.</p>\n<p>In line with Hong Kong listing regulations, the company confirmed full compliance with all applicable rules and statutory requirements. A 30-day moratorium on new share issues or sales of treasury shares is in place until 18 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02675","symbol_name":"精锋医疗-B","start_time":0,"source_url":"","article_id":"1150762872","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150762872","pubTimestamp":1781784348,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shenzhen Edge Medical Co., Ltd. disclosed that it repurchased 310,600 H shares on 18 June 2026 via on-market transactions. The shares were bought at prices ranging between HKD 38.30 and HKD 39.00,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02675":"精锋医疗-B"},"translate_title":"深圳Edge Medical执行1208万港元股份回购，库存股增至66.38万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02675":1},"content_text":"Shenzhen Edge Medical Co., Ltd. disclosed that it repurchased 310,600 H shares on 18 June 2026 via on-market transactions. The shares were bought at prices ranging between HKD 38.30 and HKD 39.00, translating into a volume-weighted average cost of HKD 38.88 per share and a total consideration of HKD 12.08 million.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) declined by 0.09% to 327.10 million shares, while total issued shares remained unchanged at 327.76 million. The repurchased stock has been retained as treasury shares, lifting the treasury balance from 353,200 to 663,800 shares.\nThe buyback was executed under the mandate approved on 18 June 2025, which authorises repurchases of up to 32.36 million shares. Cumulative repurchases under this authority now stand at 663,800 shares, equivalent to 0.21% of the share base on the mandate date.\nIn line with Hong Kong listing regulations, the company confirmed full compliance with all applicable rules and statutory requirements. A 30-day moratorium on new share issues or sales of treasury shares is in place until 18 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150762872","isCrawlerRequest":true}